Unknown

Dataset Information

0

Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation.


ABSTRACT: OBJECTIVES:Some studies suggest that bioavailable 25-dihydroxyvitamin D [25-(OH)D] is more accurate than total 25-(OH)D as an assessment of vitamin D (VitD) status in black individuals. We hypothesized that increases in bioavailable 25-(OH)D would correlate better with improvement in bone outcomes among black HIV-infected adults. DESIGN:This is a secondary analysis of AIDS Clinical Trials Group A5280, a randomized, double-blind study of VitD3 and calcium supplementation in HIV-infected participants initiating antiretroviral therapy. METHODS:Effect of VitD/calcium on total and calculated bioavailable 25-(OH)D, parathyroid hormone, bone turnover markers, and bone mineral density in black and nonblack participants were evaluated at 48 weeks. Wilcoxon signed-rank tests and Wilcoxon rank sum tests assessed within and between-race differences. RESULTS:Of 165 participants enrolled, 129 (40 black and 89 nonblack) had complete data. At baseline, black participants had lower total 25-(OH)D [median (Q1,Q3) 22.6 (15.8, 26.9) vs. 31.1 (23.1, 38.8)?ng/ml, P?

SUBMITTER: Yin MT 

PROVIDER: S-EPMC5656526 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation.

Yin Michael T MT   Chan Ellen S ES   Brown Todd T TT   Tebas Pablo P   McComsey Grace A GA   Melbourne Kathleen M KM   Napoli Andrew A   Hardin William R WR   Ribaudo Heather J HJ   Overton Edgar T ET  

AIDS (London, England) 20171101 17


<h4>Objectives</h4>Some studies suggest that bioavailable 25-dihydroxyvitamin D [25-(OH)D] is more accurate than total 25-(OH)D as an assessment of vitamin D (VitD) status in black individuals. We hypothesized that increases in bioavailable 25-(OH)D would correlate better with improvement in bone outcomes among black HIV-infected adults.<h4>Design</h4>This is a secondary analysis of AIDS Clinical Trials Group A5280, a randomized, double-blind study of VitD3 and calcium supplementation in HIV-inf  ...[more]

Similar Datasets

| S-EPMC2800808 | biostudies-literature
| S-EPMC5118123 | biostudies-literature
| S-EPMC4785726 | biostudies-other
| S-EPMC4812639 | biostudies-other
| S-EPMC9780874 | biostudies-literature
| S-EPMC5234488 | biostudies-literature
| S-EPMC3297717 | biostudies-literature
| S-EPMC7248447 | biostudies-literature
| S-EPMC3521077 | biostudies-literature
| S-EPMC2940244 | biostudies-literature